Neurology® Podcast
In part one of this two-part series, recorded at this year's AAN Annual Meeting, Dr. Gregg Day talks with Drs. Joel Salinas and Sarah Song about the evolving landscape of brain health, practical approaches to incorporating brain health assessments into routine care, and the importance of collaboration across specialties. Visit the newly launched to access trusted brain health information and stay informed. Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Justin Abbatemarco talks with Drs. Sara Marceglia and Alberto Priori about the use of artificial intelligence in neurology training, highlighting the need for formal curricula, ethical considerations, and practical applications in clinical practice. Read the related article in Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Aaron Zelikovich talks with Dr. Bhaskar Roy about the latest treatments for myasthenia gravis, comparing their efficacy and safety. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Aaron Zelikovich talks with Dr. Bhaskar Roy about the latest treatments for myasthenia gravis, comparing their efficacy and safety. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
The September 2026 Recall features four previously posted episodes highlighting updates in child neurology. The episode begins with Dr. Andrew Hershey discussing advances in the treatment of pediatric migraines. Next, Dr. Serena Orr discusses the genetic risk of migraine and post-traumatic headache in children. In the third episode, Dr. Coral Stredny reviews the management of pediatric convulsive status epilepticus, with a focus on seizure action plans and adherence to treatment protocols. The episode concludes with Dr. Scott Perry discussing approaches to improving the transition from...
info_outlineNeurology® Podcast
Dr. Jason Crowell talks with Ka-Ho Wong about national trends in Medicare reimbursement for inpatient neurologic care, including the widening gap between hospital charges and payments and its implications for healthcare policy. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
In part two of this series on the 2026 Alzheimer Association International Conference, Dr. Greg Cooper talks with Drs. Trey Bateman and Gregg Day about recent clinical trials, evolving treatment strategies, and prevention efforts. Disclosures can be found at .
info_outlineNeurology® Podcast
In part one of this series, Dr. Greg Cooper talks with Drs. Trey Bateman and Gregg Day about blood-based biomarkers, anti-amyloid therapies, and other highlights from the 2026 Alzheimer Association International Conference. Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Shuvro Roy talks with Prof. Catherine Jutzeler about how age influences neurologic and functional recovery after spinal cord injury and how these findings could inform treatment and future clinical trials. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Greg Cooper talks with Dr. Chloe Hill about comparing virtual and in-person neurology outpatient visits for new patients. Read the related article in . Disclosures can be found at .
info_outlineThe December 2024 replay wraps up the year with five previously posted episodes on autoimmune neurology. The episode begins with Drs. Michael R. Wilson and John Pluvinage discussing transcobalamin antibodies. The episode leads into an interview with Dr. Andrew McKeon, who talks about paraneoplastic CAMKV autoimmune encephalitis. In the third episode, Dr. Maarten Titulaer discusses long-term outcomes and rehab in NMDAR encephalitis. The episode continues with Prof. Zsolt Illes discussing the mortality of patients with AQP4 antibody–seropositive neuromyelitis optica spectrum disorder compared with that in the general population. In the final episode, Drs. Marius Ringelstein and Ilya Ayzenberg discuss the effectiveness and safety of Eculizumab in routine clinical care.
Podcast Links:
Transcobalamin receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency
Paraneoplastic CAMKV Autoimmune Encephalitis
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis
Mortality in a Danish NMO Cohort
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
Article Links:
Transcobalamin Receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Disclosures can be found at Neurology.org.